
possibile iscriversi on line tramite il sito www. Monte-Carlo, extending along the coast, nearly parallel to the railway. Carlo Enrico Traverso Direttore Clinica Oculistica, Universit di Genova RESPONSABILE SCIENTIFICO Massimo Nicol Centro Retina Medica - Clinica Oculistica, Universit di Genova GENOVA 22 GENNAIO 2021 VIRTUAL EDITION ISCRIZIONE L’iscrizione al webinar gratuita, ma necessaria. A significant correlation was found between break-up time and both central corneal sensitivity and the number of fibers.Ĭonclusion: The use of a preservative-free artificial substitute in association with a topical therapy with chronic preservative could increase the compliance of patients. Carlo Traverso and the Online Distributed Proofreading Team START OF THE. Results: After the artificial substitute, corneal and conjunctival sensitivity significantly ( P<0.001) improved at T1 and T3 compared to the baseline. Genetics, Maternal and Child Health, University of Genova, Genova, Italy. All patients were examined with a digital corneal confocal laser-scanning microscope (HRT II Rostock Cornea Module Heidelberg Engineering GmbH) and Cochet-Bonnet corneal esthesiometer. Wagih Aclimandos 2, Catherine Creuzot-Garcher 3, Carlo-Enrico Traverso 4. The participants were subjected to clinical and instrumental evaluation at baseline (T0), after 1 month (T1) and after 3 months (T3) of treatment.
Carlo traverso genova free#
Preservative-free artificial tears (0.5% tamarind seed polysaccharide 0.5 ® eye drops single-dose preservative free ) were prescribed thrice per day. All the patients were treated with a prostaglandin analog with preservative for at least 1 year.

Finland Carlo Traverso Department of Mathematics, University of Pisa Via F. Twenty glaucomatous patients were recruited. Mario Raimondo Department of Mathematics, University of Genova Via L.B.

Methods: This study was prospective, longitudinal, and single arm. Purpose: To evaluate whether a tear substitute can improve corneal subepithelial nerve plexus and corneal sensitivity in glaucomatous patients.
